Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial
Background This study sought to evaluate the safety and efficacy of the NOYA stent which is a Cobalt Chromium-based sirolimus-eluting stent (SES) with DL-Polylactide biodegradable polymer (Medfavour Medical,Beijing, China) in treating de novo coronary artery lesions.
DOU Ke-fei XU Bo YANG Yue-jin GAO Run-lin
Fuwai Hospital,National Center for Cardiovascular Diseases of China,Beijing,China
国内会议
北京
英文
35-36
2013-03-20(万方平台首次上网日期,不代表论文的发表时间)